Mieke  Hemelrijck: Guy’s Cancer RWE Programme Showcased at ESMO AI 2026
Mieke Van Hemelrijck/ LinkedIn

Mieke Hemelrijck: Guy’s Cancer RWE Programme Showcased at ESMO AI 2026

Mieke  Hemelrijck, Professor in Cancer Epidemiology at King’s College London and Academic Lead of Guy’s Cancer Real-World Evidence Programme at Guy’s and St Thomas’ NHS Foundation Trust, shared on LinkedIn:

“Great to be at ESMO AI and Digital Oncology Congress 2026 in Berlin with Ailbhe Lawlor, who is presenting our Guy’s Cancer Real-World Evidence Programme as a learning health system in action.

Today’s discussions, particularly the closing session on real-world data, have resonated strongly: moving from RWD to robust real-world evidence, ensuring data quality and meaningful endpoints, and, crucially, translating that evidence back into clinical practice.

It is great to see how closely this aligns with what we have been building through the Guy’s Cancer RWE Programme: a genuinely collaborative approach bringing together clinicians, researchers, data expertise and, importantly, patients and the public to create a continuous cycle between clinical practice, research questions, data, evidence and improvements in care.

Proud to see Ailbhe showcasing this work at ESMO AI  and Digital Oncology and to be part of the wider conversation about how we turn increasingly rich health data into evidence that makes a difference for patients.”

Mieke Hemelrijck: Guy’s Cancer RWE Programme Showcased at ESMO AI 2026

About Guy’s Cancer Real-World Evidence Programme at ESMO AI 2026

The ESMO AI & Digital Oncology Congress 2026, held on November 16–18 in Berlin, Germany, brings together oncology professionals, researchers and digital health experts to explore advances in artificial intelligence, real-world data and technology-driven cancer care. The meeting emphasizes clinical implementation, data quality, ethical considerations and responsible innovation.

The Guy’s Cancer Real-World Evidence (RWE) Programme, a collaboration between King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, aims to transform routinely collected healthcare information into reliable evidence that supports cancer research and clinical decision-making.

The programme builds on the Guy’s Cancer Cohort, which brings together clinical information from patients receiving cancer care. Its research infrastructure supports the investigation of treatment pathways, patient characteristics and clinical outcomes, helping researchers answer questions that may not be fully addressed by conventional clinical trials.

Read more here.

Mieke Hemelrijck: Guy’s Cancer RWE Programme Showcased at ESMO AI 2026